NFKB1 and ductal breast carcinoma in situ: Together, our results suggest that FN-β1-integrin via NF-κB feedback signaling iscritical mediators of invasive progression post-IR, and could be therapeutic targets to suppress invasive recurrence after radiation treatment of DCIS.